In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation

Endocrinology
E L WebsterG P Chrousos

Abstract

Corticotropin-releasing hormone (CRH) secreted from the hypothalamus is the major regulator of pituitary ACTH release and consequent glucocorticoid secretion. CRH secreted in the periphery also acts as a proinflammatory modulator. CRH receptors (CRH-R1, R2alpha, R2beta) exhibit a specific tissue distribution. Antalarmin, a novel pyrrolopyrimidine compound, displaced 12SI-oCRH binding in rat pituitary, frontal cortex and cerebellum, but not heart, consistent with antagonism at the CRHR1 receptor. In vivo antalarmnin (20 mg/kg body wt.) significantly inhibited CRH-stimulated ACTH release and carageenin-induced subcutaneous inflammation in rats. Antalarmin, or its analogs, hold therapeutic promise in disorders with putative CRH hypersecretion, such as melancholic depression and inflammatory disorders.

Citations

Oct 30, 2007·Psychopharmacology·Sheila E SpecioGeorge F Koob
Feb 3, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Joseph G Oberlander, Leslie P Henderson
Mar 25, 2006·Nature Reviews. Immunology·Esther M Sternberg
Dec 13, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Udi E GhitzaYavin Shaham
May 20, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Susan K WoodJames H Woods
May 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Pauline M AntonCharalabos Pothoulakis
Oct 4, 2006·Proceedings of the National Academy of Sciences of the United States of America·A C HanssonR Ciccocioppo
Mar 28, 2012·Proceedings of the National Academy of Sciences of the United States of America·Robert A RissmanPaul E Sawchenko
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·K P KaralisJ A Majzoub
Jul 8, 1999·Proceedings of the National Academy of Sciences of the United States of America·S C WeningerJ A Majzoub
Aug 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·S M NielsenW W Vale
Sep 9, 2010·American Journal of Physiology. Endocrinology and Metabolism·S M HerodJ L Cameron
Sep 9, 2010·The Journal of Clinical Endocrinology and Metabolism·Phyllis W SpeiserUNKNOWN Endocrine Society
Nov 28, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Lynn G KirbySheryl G Beck
Aug 14, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Arati S KreibichJulie A Blendy
Oct 6, 2007·Molecular Neurobiology·Gerhard Rammes, Rainer Rupprecht
Dec 24, 2011·Journal of Neurochemistry·Kabirullah LutfyTheodore C Friedman
Oct 14, 2004·The Journal of Allergy and Clinical Immunology·Eric S SilvermanJoseph A Majzoub
Feb 1, 2017·Neuropharmacology·Angelo ContarinoPier-Vincenzo Piazza
Jan 22, 2002·Neuroscience and Biobehavioral Reviews·L K Takahashi
Feb 28, 2001·Expert Opinion on Investigational Drugs·T C Theoharides, G R Sant
Apr 3, 2001·Expert Opinion on Investigational Drugs·S C Heinrichs, Y Taché
Nov 22, 2007·Expert Opinion on Therapeutic Targets·Susan K Wood, James H Woods

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.